Marex Group’s GE HealthCare GEHC Stock Holding History

Marex Group’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,152	Closed	-$246K	–	744
2024 Q4	$246K	Buy	+3,152	New	+$268K	﹤0.01%	489

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marex Group's GEHC Position: Q1 2025 in Review

Marex Group sold out of GE HealthCare (GEHC) in Q1 2025, closing a stake of 3,152 shares — an estimated $246K sold.

Marex Group first reported a position in GEHC in Q4 2024 and held it in 1 quarter. The position peaked at $246K in Q4 2024. 1,367 funds tracked by Wall St. Rank hold GEHC as of Q1 2025.

Marex Group reported no remaining GE HealthCare position as of Q1 2025 after selling out during the quarter.
Marex Group sold 3,152 GE HealthCare shares in Q1 2025, an estimated $246K.
Marex Group first reported a position in GE HealthCare in Q4 2024 and held it in 1 quarter.
Marex Group's GE HealthCare position peaked at $246K in Q4 2024.
1,367 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2025.

Based on Marex Group's 13F filing for Q1 2025, filed 2 Apr 2026.